Neuroscience researchers suggest that utilizing fMRI studies could help to provide biomarkers for the diagnosis of depression. A recent fMRI study of patients with depression showed marked abnormal activations in the medial prefronal cortex. Researchers believe that by identifying the neurobiological markers for depression, psychiatrists can tailor medications and therapies to suit the needs of individual patients.
